The Journal of Clinical Pharmacology

Sentinel Dosing—Time for a Risk-Based Approach?

Pub Date : 2024-11-24 DOI: 10.1002/jcph.6167 Peter L. Bonate PhD, FCP, FAAPS, FISoP, Mark Rogge PhD, FCP, Jean-Michel Gries PharmD, PhD, FCP, Alexander J. Prokopienko PharmD, PhD, Sudhakar M. Pai PhD, FCP, ACCP Public Policy Committee

Training the Next Generation of Pediatric Clinical Pharmacologists: Insights and Trainee Perspectives Over 10 Years

Pub Date : 2024-11-13 DOI: 10.1002/jcph.6155 Rachel L. Randell MD, MSCR, Rose Gelineau-Morel MD, Sydney Thomas PhD, Daniel Gonzalez PharmD, PhD, J. Steven Leeder PharmD, PhD, Christoph P. Hornik MD, PhD, MPH

Exposure–Response Analysis of Tofacitinib in Active Psoriatic Arthritis: Results from Two Phase 3 Studies

Pub Date : 2024-10-25 DOI: 10.1002/jcph.6147 Sujatha Menon PhD, Satoshi Shoji PhD, Shinichi Tsuchiwata MS, Lara Fallon PhD, Keith Kanik MD